M L Essink-Bot

A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group.

M. Essink‐bot, P. Kramers, J. Melse, 2000, American journal of public health.

The comparability and reliability of five health-state valuation methods.

G. Bonsel, M. Essink‐bot, P. Krabbe, 1997, Social science & medicine.

An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument.

N K Aaronson, G. Bonsel, N. Aaronson, 1997, Medical care.

Short-term effects of population-based screening for prostate cancer on health-related quality of life.

H. D. de Koning, M. Essink‐bot, P. J. van der Maas, 1998, Journal of the National Cancer Institute.

Generalizability of valuations on health states collected with the EuroQolc-questionnaire.

G. Bonsel, M. Essink‐bot, M. Stouthard, 1993, Health economics.

The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system.

G. Bonsel, M. Essink‐bot, M. Stouthard, 1999, Journal of clinical epidemiology.

Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?

H. D. de Koning, M. Essink‐bot, E. Steegers, 2011, Patient Education and Counseling.

What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment.

E W Steyerberg, J. Habbema, E. Kuipers, 2010, European journal of cancer.

Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D.

M. Essink‐bot, B. van Hout, J. McDonnell, 1999, Journal of health economics.